← Snapshot 21

Orange Book snapshot 21: Products

Products page 295 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
14702A213532002LEVETIRACETAMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSLEVETIRACETAM IN SODIUM CHLORIDENEXUS PHARMS1GM/100ML (10MG/ML)AP["AP"]2020-07-06Jul 6, 2020NoNoNoRXNEXUS PHARMACEUTICALS INC2478d0173f02875a3f78e9730f089ec64513cc309340481f17dc3bf2a087f145
14703A213532003LEVETIRACETAMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSLEVETIRACETAM IN SODIUM CHLORIDENEXUS PHARMS1.5GM/100ML (15MG/ML)AP["AP"]2020-07-06Jul 6, 2020NoNoNoRXNEXUS PHARMACEUTICALS INCe34d1e98524559a79a101a8bae750d02015b3868361b153f1595a94827327255
14704A213532001LEVETIRACETAMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSLEVETIRACETAM IN SODIUM CHLORIDENEXUS PHARMS500MG/100ML (5MG/ML)AP["AP"]2020-07-06Jul 6, 2020NoNoNoRXNEXUS PHARMACEUTICALS INC2543778be01670fbed16ef0367ebc99e69dc7b1104f371d652c96d86c3320e29
14705N021625001ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN KINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSM.V.I. ADULTHOSPIRA200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL[]2004-01-30Jan 30, 2004NoYesYesRXHOSPIRA INCfc1371e7a7525bcef68f73c4f59def07700b76eb74fd394d9ebc70a932f15176
14706N021643001ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN KINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSM.V.I. ADULT (PHARMACY BULK PACKAGE)HOSPIRA200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0.15MG/5ML[]2004-02-18Feb 18, 2004NoYesYesRXHOSPIRA INCeb5d3b404f21d547c160a05a08a8f7dd72e4be4d224e36bc217d9b4392fe817d
14707A075811001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNAFRESENIUS KABI USA100MG/MLAP["AP"]2001-04-26Apr 26, 2001NoNoNoRXFRESENIUS KABI USA LLC3c75aed399c921a72735bb64c0f1c413851252883a1ae9905bde215571e028bb
14708A206992001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNAGLAND PHARMA LTD100MG/MLAP["AP"]2017-12-18Dec 18, 2017NoNoNoRXGLAND PHARMA LTD8596da934576fa8e0f67337f2936e7e97e8eb5ad99a4456486b4d78c46f90bb2
14709A076488001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNAMYLAN INSTITUTIONAL100MG/ML[]2012-03-08Mar 8, 2012NoNoNoDISCNMYLAN INSTITUTIONAL LLC707610899f60bdf0350c6b7f2f3b0e57b06c461b616a12d71fc07cd01407d5f3
14710A203364001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNAMYLAN LABS LTD100MG/ML[]2014-07-18Jul 18, 2014NoNoNoDISCNMYLAN LABORATORIES LTD2121c5eb36cf0d878a29e44415345c87c4da9faf63a0730e7637cd7b8de5ef0d
14711A090913001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNASAGENT PHARMS INC100MG/MLAP["AP"]2010-04-13Apr 13, 2010NoNoNoRXSAGENT PHARMACEUTICALS INC0b34c6a3937311080a1acb7e73536dcc14c50014a407697a642c43f047cdfd5a
14712A075764001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNATEVA PHARMS USA100MG/ML[]2001-04-27Apr 27, 2001NoNoNoDISCNTEVA PHARMACEUTICALS USA8739eb0767a3e35ee3b37a3022d0271009ebfeeee6fdb6acf03570f4a568fec8
14713A075739001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNAWEST-WARD PHARMS INT100MG/MLAP["AP"]2004-01-09Jan 9, 2004NoNoNoRXWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD9a4829b352e8595771b3dc6c4969b765b032ecc092f51b6c74905efb1394a5d3
14714N019884001MESNAINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMESNEXBAXTER HLTHCARE100MG/MLAP["AP"]1988-12-30Dec 30, 1988NoYesYesRXBAXTER HEALTHCARE CORP15fb82b9937faa8e0c00d5c7efb597ec4e63294c0a20c6766d90b2a17cd19291
14715A208366001MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMICAFUNGIN SODIUMAPOTEXEQ 50MG BASE/VIALAP["AP"]2020-11-05Nov 5, 2020NoNoNoRXAPOTEX INCfce890f924dfb9ed9893d0eff86f61509ff21ee2ee977e721dcfdd2bca6eb46b
14716A208366002MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMICAFUNGIN SODIUMAPOTEXEQ 100MG BASE/VIALAP["AP"]2020-11-05Nov 5, 2020NoNoNoRXAPOTEX INC7a8ac1df2e2237c070592a459d4f556c84813cf12ce17eb3a1fa705cd73f93b2
14717A207344001MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMICAFUNGIN SODIUMFRESENIUS KABI USAEQ 50MG BASE/VIALAP["AP"]2019-05-17May 17, 2019NoNoNoRXFRESENIUS KABI USA LLCe7dd8a48c9ec6701bda136747bf6e9f5703f23b9f92501ec597e20ba535650fe
14718A207344002MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMICAFUNGIN SODIUMFRESENIUS KABI USAEQ 100MG BASE/VIALAP["AP"]2019-05-17May 17, 2019NoNoNoRXFRESENIUS KABI USA LLC1d4f4f358fe460b657e4e84706bb33a0782a674355562792300c7217de24e52e
14719N021357001GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCEBRACCO2.645GM/5ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INC86a01f8b1ab5d7609a153efc07c205d301cf3ad825393c55a17cf0ad92cf1d8a
14720N021357002GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCEBRACCO5.29GM/10ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INC897c4a7864073feff8b3e7637d30e9b557cebf7770721d266457dca4c399ab71
14721N021357003GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCEBRACCO7.935GM/15ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INCf3f57a2aab0b66c9061ac03fa101682b2f036bc1cd1d7b5c7565c88bd506f977
14722N021357004GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCEBRACCO10.58GM/20ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INCb3c193fefe9dd1a81a122c05020bc8c126cb89ba382f2d99eea6d683fc53c74a
14723N021358001GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCE MULTIPACKBRACCO26.45GM/50ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INCde08767a5beed26e7d5eaf168bc741465d5dba22b389109a7779fe6013252be7
14724N021358002GADOBENATE DIMEGLUMINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMULTIHANCE MULTIPACKBRACCO52.9GM/100ML (529MG/ML)[]2004-11-23Nov 23, 2004NoYesYesRXBRACCO DIAGNOSTICS INC51e8800112ac1574ac924241bd6684dfb576142a4142b022a23fc0fb73422216
14725N021506002MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMYCAMINEASTELLASEQ 50MG BASE/VIALAP["AP"]2005-03-16Mar 16, 2005NoYesYesRXASTELLAS PHARMA US INCe5a69d6401eee66a681f4ed7f8c6283d1f9e1abb962669e8dacd0f6a479b6735
14726N021506003MICAFUNGIN SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSMYCAMINEASTELLASEQ 100MG BASE/VIALAP["AP"]2006-06-27Jun 27, 2006NoYesYesRXASTELLAS PHARMA US INC7c4454b0c861977474a7501a2d7b5fe31588093c6520aac50e65d4f12fcd50c7
14727N021903001IBUPROFEN LYSINEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSNEOPROFENRECORDATI RAREEQ 20MG BASE/2ML (EQ 10MG BASE/ML)AP["AP"]2006-04-13Apr 13, 2006NoYesYesRXRECORDATI RARE DISEASES INC1b159087c3762cf4a3e773b3f2c42f227fb2e188a02e752c822c98502307ffde
14728N021689001ESOMEPRAZOLE SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSNEXIUM IVASTRAZENECAEQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]2005-03-31Mar 31, 2005NoYesNoDISCNASTRAZENECA PHARMACEUTICALS LP8620159bc1842439ddefe526a87410ad9f5bc82b735e2fe98a4fa58d6ec7eb09
14729N021689002ESOMEPRAZOLE SODIUMINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSNEXIUM IVASTRAZENECAEQ 40MG BASE/VIALAP["AP"]2005-03-31Mar 31, 2005NoYesYesRXASTRAZENECA PHARMACEUTICALS LP6f14992e376d9598bccba4d88e96d46cb61d5334037b4607e7443742f4392f0f
14730N022276002NICARDIPINE HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSNICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEEXELA PHARMA SCIENCE20MG/200ML (0.1MG/ML)[]2016-04-07Apr 7, 2016NoYesYesRXEXELA PHARMA SCIENCES86d98f6ea45b12e667368e1d446e7acfc98a1f000f21c2b86eb24e53e0bf7006
14731N022276003NICARDIPINE HYDROCHLORIDEINJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSNICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEEXELA PHARMA SCIENCE40MG/200ML (0.2MG/ML)[]2016-04-07Apr 7, 2016NoYesYesRXEXELA PHARMA SCIENCES8c5f3b7f419a01475e08627611e2be6c13e1be9032147542ca9a59a741c5cd44
14732A207474001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACCORD HLTHCARE50MG/10ML (5MG/ML)AP["AP"]2017-03-21Mar 21, 2017NoNoNoRXACCORD HEALTHCARE INC6e01de2cf7c80cbc2b02665b195f5e5c21efcdaeaf7a04191f434d58d46b9a89
14733A207474002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACCORD HLTHCARE100MG/20ML (5MG/ML)AP["AP"]2017-03-21Mar 21, 2017NoNoNoRXACCORD HEALTHCARE INC792fbbaa216bd405ea941046741764a0cd76dc6ac76498dd33aa8547e37ac3c5
14734A207474003OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACCORD HLTHCARE200MG/40ML (5MG/ML)[]2017-03-21Mar 21, 2017NoNoNoDISCNACCORD HEALTHCARE INCd28c2cadc93ba80ea81c9bd305b15d65373975d3fc7951891453fdb42df76f54
14735A204880001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACTAVIS LLC50MG/10ML (5MG/ML)AP["AP"]2018-03-05Mar 5, 2018NoNoNoRXACTAVIS LLC AN INDIRECT WHOLLY-OWNED SUB OF TEVA PHARMACEUTICALS USA INC72a78ad22a0ec86e4285353b754f2795bc3ab489b043bf9f2fd7490a0dc66f2a
14736A204880002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACTAVIS LLC100MG/20ML (5MG/ML)AP["AP"]2018-03-05Mar 5, 2018NoNoNoRXACTAVIS LLC AN INDIRECT WHOLLY-OWNED SUB OF TEVA PHARMACEUTICALS USA INC85d9611765cc97187d2a936df5471c380a7582163906721193819a4b4160dabc
14737A078803001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACTAVIS TOTOWA50MG/VIALAP["AP"]2012-08-08Aug 8, 2012NoNoYesRXACTAVIS TOTOWA LLC91eff32d3d8ee47b14e2e0761da7f4ae8b7e3043b517969035a1f0e24f377129
14738A078803002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINACTAVIS TOTOWA100MG/VIALAP["AP"]2012-08-08Aug 8, 2012NoNoYesRXACTAVIS TOTOWA LLC9a89977c645acbd883609cf9aa4b431ac804f2e8341037f6e6b87ad026683faf
14739A204378001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINAM REGENT50MG/10ML (5MG/ML)[]2017-05-12May 12, 2017NoNoNoDISCNAMERICAN REGENT INCd00d807f08291589b25aad5cea6319dd6e1b3ef5c61f0d2743affde076afd43e
14740A204378002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINAM REGENT100MG/20ML (5MG/ML)[]2017-05-12May 12, 2017NoNoNoDISCNAMERICAN REGENT INC73476d999f649421a07d705c16bb1e6c5c407b6dc81b8e870823f235769fd23e
14741A208523001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINCIPLA50MG/10ML (5MG/ML)AP["AP"]2017-02-10Feb 10, 2017NoNoNoRXCIPLA LTD2e9a5488fd8128086c5aa536e5054644cca53154861e4b82793c864722af6cc2
14742A208523002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINCIPLA100MG/20ML (5MG/ML)AP["AP"]2017-02-10Feb 10, 2017NoNoNoRXCIPLA LTD342aaa80fd357403fe8e782f0dafd4d56878d83394ced16263b91053c368d37d
14743A205529001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINEUGIA PHARMA50MG/10ML (5MG/ML)AP["AP"]2017-09-06Sep 6, 2017NoNoNoRXEUGIA PHARMA SPECIALITIES LTD010df905ece86ca022f3974231c59f994a2496aa1f3787d3c96c43569506802c
14744A205529002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINEUGIA PHARMA100MG/20ML (5MG/ML)AP["AP"]2017-09-06Sep 6, 2017NoNoNoRXEUGIA PHARMA SPECIALITIES LTD0618ca8c72505d76b6bf1e147681fda6d8ab4e7f1c61a50faa31d58f6aec3121
14745A078810001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI ONCOL50MG/VIAL[]2009-08-07Aug 7, 2009NoNoNoDISCNFRESENIUS KABI ONCOLOGY PLCda884378325852c033b1792b61ac36a60028a3f8a49eedbfeec9c9d782ae9613
14746A078810002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI ONCOL100MG/VIAL[]2009-08-07Aug 7, 2009NoNoNoDISCNFRESENIUS KABI ONCOLOGY PLC28801feca6c1d6f025a444d14b45c99507b100cd24ddd45ff1910b319028cc6a
14747A078811001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA50MG/10ML (5MG/ML)AP["AP"]2010-06-10Jun 10, 2010NoNoNoRXFRESENIUS KABI USA LLCa5f5392eb5337012aef7a1b1cae460e6e5e680acfe89cd93a24027276b9699fb
14748A078811002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA100MG/20ML (5MG/ML)AP["AP"]2010-06-10Jun 10, 2010NoNoNoRXFRESENIUS KABI USA LLC2d27b07858aeefbe74a01b730c6870cd33f4723ed9a97ad2b5843bc254c7b4bc
14749A078819001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA50MG/VIALAP["AP"]2010-06-02Jun 2, 2010NoNoNoRXFRESENIUS KABI USA LLC4aa7906f7902614344ce743edabc696567c5b046f3cedb174435f5a1a9f4141b
14750A090030001OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA50MG/10ML (5MG/ML)AP["AP"]2017-01-31Jan 31, 2017NoNoNoRXFRESENIUS KABI USA LLCd9feab749e5d9d1f9a48211d444f1cb0fcc00896e066d7825730606bb9e536ac
14751A078819002OXALIPLATININJECTABLE;INTRAVENOUSINJECTABLEINTRAVENOUSOXALIPLATINFRESENIUS KABI USA100MG/VIALAP["AP"]2010-06-02Jun 2, 2010NoNoNoRXFRESENIUS KABI USA LLC8a7ab51f4fe40bf2460bc65fa86193c353a4ed3ad8cf578e3100c4e8a0281da3